HRI Portal – health • research • innovation

  • About Us
    • About Research Canada
    • Sponsors
    • Contact
  • Information on Health Research
    and Innovation in Canada
    • The Current State of Health Research
      and Innovation in Canada
    • Research and Innovation in Action
    • Responding to and Recovering from the COVID-19 Pandemic
    • CanadaSpeaks! 2019
    • Patient Stories
    • What’s Being Said:
      Blog and News
  • Resources for
    Advocates
    • Advocacy Messages
    • Tips for Effective Advocacy
      • Quick Tips for Effective Advocacy
      • Meeting with Candidates: Policy Questions and Answers
      • Using Social Media for Health Research Advocacy
      • Maximizing Your Impact: Town Halls
    • About Your Candidates
    • Advocates’ Toolkit
  • Resources for
    Candidates
    • Information on Health Research and Innovation

What's Being Said

  1. Home
  2. › Information on Health Research and Innovation in Canada
  3. › What's Being Said
  4. › The Canadian Forum for Rare Disease Innovators

The Canadian Forum for Rare Disease Innovators

October 15, 2019September 11, 2019

Incredible scientific and technological advances in recent years have improved our collective understanding of many rare diseases. This is a very exciting time for the rare disease community. These diseases are often severe conditions that affect a very small population – fewer than one in 2,000 Canadians.

However, too many Canadians cannot benefit from these technologies. Rare disease therapies are launched in Canada later than in the United States and/or Europe – a median of 340 days later[1] – and, in many cases, are not even available for patients in Canada.

That is because the lengthy Canadian pharmaceutical review and approval system is not organized appropriately to account for the distinct nature of how medications designed to treat small patient populations are developed. Canada is virtually alone in not using tailored review processes and incentives to encourage manufacturers to bring rare disease treatments to patients.

In recent reports, both the House of Commons Standing Committee on Health,[2] and the federal government’s Advisory Council on the Implementation of National Pharmacare[3] have recognized the need for a distinct approach to reviewing and approving rare disease treatments. RAREi will continue to foster a dialogue between rare disease stakeholders and policy makers to ensure that people affected by rare diseases can access important new therapies.

 

[1] Rawson, N., Fraser Institute, Regulatory, Reimbursement, and Pricing Barriers to Accessing Drugs for Rare Disorders in Canada, 2018: https://www.fraserinstitute.org/sites/default/files/barriers-to-accessing-drugs-for-rare-disorders-in-canada.pdf

[2] RAREi – The Canadian Forum for Rare Disease Innovators, Unique approach needed: Addressing barriers to accessing rare disease treatments, October 31, 2018: https://www.linkedin.com/feed/update/urn:li:activity:6556579888877363200. See also Standing Committee on Health, Canadians Affected by Rare Diseases and Disorders: Improving Access to Treatment, February 2019: https://www.ourcommons.ca/DocumentViewer/en/42-1/HESA/report-22/.

[3] Advisory Council on the Implementation of National Pharmacare, A Prescription for Canada: Achieving Pharmacare for All, June 12, 2019: https://www.canada.ca/en/health-canada/corporate/about-health-canada/public-engagement/external-advisory-bodies/implementation-national-pharmacare/final-report.html.

The Canadian Forum for Rare Disease Innovators (RAREi) is a group of the Canadian operation of global biopharmaceutical companies with a specific focus on researching, developing and commercializing treatments for rare diseases.

The 2019 election campaign: a missed opportunityProducing Great Outcomes for Patients Locally and Globally with Made-in-Canada Treatments
  • AstraZeneca
  • Innovative Medicines Canada - Médicaments novateurs Canada
  • Roche

Contact Us

Tweets

  • 6 months ago RT @hri_portal: New on the Guest Blog: Changing the course of #arthritis Pediatric arthritis affects over 25K children and youth, but @Ar…
  • 6 months ago RT @KBI_UHN: Learn all about the latest research in #concussion & traumatic #braininjury in Episode 7 of @KBI_UHN's #YourComplexBrain #podc…
  • 6 months ago RT @McMasterPMM: Read more about Dr. Fiona Smaill's work on the aerosol vaccine here: https://t.co/dyN23bKWNe
  • 6 months ago A huge thank you to our Members, Parliamentarians and guests who joined us for our 18th Annual General Meeting! Ch… https://t.co/KaVxmHlatq

About Research Canada

Research Canada is a national, broad-based alliance dedicated to increasing investments in health research through collaborative advocacy. We believe health research is shared benefit, shared responsibility and an investment in Canada’s future. We engage government, academia, industry and non-profit sectors to build support for balanced and long-term health research funding – investments that strengthen Canada’s innovation system and lead to better health, sustainable health care, new commercialization opportunities, and skilled jobs for Canadians.

Research Canada: An Alliance for Health Discovery / Recherche Canada : Une alliance pour les découvertes en santé
Your Candidates, Your Health Your Candidates, Your Health
HRI Portal – health • research • innovation
  • Sponsors
  • Health Research
    and Innovation
  • Resources for
    Candidates
  • Resources for
    Advocates
  • What’s Being Said:
    Blog and News
  • Contact
Research Canada/Recherche Canada © 2019 | All Rights Reserved | Tous droits réservés.